Accumulation by rat vas deferens of debrisoquine and guanoxan.
D000818:Animals; D000959:Antihypertensive Agents / Q000378:metabolism*; D003042:Cocaine / Q000494:pharmacology; D003647:Debrisoquin / Q000037:antagonists & inhibitors / Q000378:metabolism; D004077:Digoxin / Q000494:pharmacology; D066298:In Vitro Techniques; D007546:Isoquinolines / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism; D013565:Sympatholytics / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D013997:Time Factors; D014649:Vas Deferens / Q000378:metabolism*
D000959:Antihypertensive Agents; D007546:Isoquinolines; D013565:Sympatholytics; D012701:Serotonin; D004077:Digoxin; D012964:Sodium; D003042:Cocaine; D003647:Debrisoquin; D009638:Norepinephrine